The aim of this study was to analyze the effect of these cysts on the IVF outcomes.Materials and Methods: Out of 981 IVF cycles, 78 with ovarian cysts were retrospectively analyzed with respect to the demographic characteristics, hormonal outcomes, and fertilization, implantation and clinical pregnancy rates.Results: The metaphase II oocyte ratio, fertilization rate and percentage of high quality embryos (grade 1) were significantly higher in the cyst-negative group (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: The gonadotropin-releasing hormone-agonist (GnRH-a) treatment during in vitro fertilization (IVF) sometimes causes a functional ovarian cyst during the administration period before gonadotropin stimulation, as an undesired event.
📊
Key Findings & Data:Objective: The gonadotropin-releasing hormone-agonist (GnRH-a) treatment during in vitro fertilization (IVF) sometimes causes a functional ovarian cyst during the administration period before gonadotropin stimulation, as an undesired event.
💡
Conclusion & Impact:The aim of this study was to analyze the effect of these cysts on the IVF outcomes.Materials and Methods: Out of 981 IVF cycles, 78 with ovarian cysts were retrospectively analyzed with respect to the demographic characteristics, hormonal outcomes, and fertilization, implantation and clinical pregnancy rates.Results: The metaphase II oocyte ratio, fertilization rate and percentage of high quality embryos (grade 1) were significantly higher in the cyst-negative group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: The gonadotropin-releasing hormone-agonist (GnRH-a) treatment during in vitro fertilization (IVF) sometimes causes a functional ovarian cyst during the administration period before gonadotropin stimulation, as an undesired event. The aim of this study was to analyze the effect of these cysts on the IVF outcomes.Materials and Methods: Out of 981 IVF cycles, 78 with ovarian cysts were retrospectively analyzed with respect to the demographic characteristics, hormonal outcomes, and fertilization, implantation and clinical pregnancy rates.Results: The metaphase II oocyte ratio, fertilization rate and percentage of high quality embryos (grade 1) were significantly higher in the cyst-negative group (p
🔖
Cite This Article
AKSAKAL, F. N., MOLLAMAHMUTOĞLU, L., HAMDEMİR, S., ERYILMAZ, Ö. G., DOĞAN, M., SARIKAYA, E. (2022). Ovarian cyst formation following gonadotropin-releasing hormone-agonist administration decreases the oocyte quality in IVF cycles. Balkan Medical Journal, Cilt: 29 - Sayı: 2, 197–200. https://ajindex.com/articles/461702
Fiszbajn GE, Lipowicz RB, Elberger L, Grabia A, Papier SD, Olmedo SBP, et al. Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction. J Assist Reprod Genet 2000
[CrossRef] 2. Feldberg D, Goldman J, Ashkenazi J, Shelef M, Dicker D, Hart J. Ovarian cyst aspiration during induction of ovulation for IVF. Hum Reprod 1987
Segal S, Schifren JL, Isaacson KB, Leykin L, Chang Y, Pal L, et al. Effects of a baseline ovarian cyst on the outcomes of in vitro fertilization- embryo transfer. Fertil Steril. 1999
[CrossRef] 4. Qublan HS, Amarin Z, Tahat YA, Smadi AZ, Kilani M. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact. Hum Reprod 2006
[CrossRef] 5. Feldberg D, Ashkenazi J, Dicker D, Yeshaya A, Goldman GA, Goldman JA. Ovarian cyst formation: a complication of gonadotropinreleasing hormone agonist therapy. Fertil Steril 1989
Herman A, Ron-El R, Golan A, Nahum H, Soffer Y, Caspi E. Follicle cysts after menstrual versus midluteal administration of gonadotropin- releasing hormone analog in in vitro fertilization. Fertil Steril 1990
Jenkins JM, Davies DW, Anthony F, Wood P, Gadd SG, Watson RH, et al. The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles. Hum Reprod 1992
Ron-El R, Herman A, Golan A, Raziel A, Soffer Y, Caspi E. Follicle cyst formation following long acting gonadotropin-releasing hormone analog administration. Fertil Steril 1989
Tarlatzis BC, Bili H, Bontis J, Lagos S, Vatev I, Mantalenakis S. Follicle cyst formation after administration of different gonadotropinreleasing hormone analogues for assisted reproduction. Hum Reprod 1994
Biljan MM, Lapensee L, Mahutte NG, Bissonnette F, Hemmings R, Tan SL. Effects of functional ovarian cysts detected on the 7th day of gonadotropin-releasing hormone analog administration on the outcome of IVF treatment. Fertil Steril 2000
[CrossRef] 11. Hornstein MD, Barbieri RL, Ravnikar VA, McShane PM. The effects of baseline ovarian cysts on the clinical response to controlled ovarian hyperstimulation in an in vitro fertilization program. Fertil Steril 1989
Keltz MD, Jones EE, Duleba AJ. Baseline cyst formation after luteal phase gonadotropin releasing hormone agonist administration is linked to poor in vitro fertilization outcome. Fertil Steril 1